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The granting of clinical staff privileges to physicians is aprimary mechanism used by institutions to uphold the
quality of patient care. The Joint Commission on Accredita-
tion of Healthcare Organizations requires that the granting of
continuing medical staff privileges be based on assessments
of applicants in accordance with professional criteria speci-
fied in the medical staff bylaws. Physicians and other health-
care providers are thus charged with identifying the criteria
that constitute professional competence and with evaluating
their peers accordingly. The process of evaluating clinical
knowledge and competence is often constrained by the
evaluator’s knowledge and ability to elicit the appropriate
information, a problem that is compounded by the growing
number of highly specialized procedures for which privileges
are requested.
The American College of Cardiology (ACC)/American
Heart Association (AHA)/American College of Physicians–
American Society of Internal Medicine (ACP-ASIM) Task
Force on Clinical Competence was formed in 1998 to develop
recommendations to attain and maintain the cognitive and
technical skills necessary for the competency performance of
a specific cardiovascular service, procedure, or technology.
These documents are evidence based, and where evidence is
not available, expert opinion is used to formulate recommen-
dations. Indications and contraindications for specific ser-
vices or procedures are not included in the scope of these
guidelines. Recommendations are intended to assist those
who must judge the competence of cardiovascular healthcare
providers who are entering practice for the first time and
those who are in practice and undergo periodic review of their
practice expertise. Because the assessment of competence is
complex and multidimensional, the isolated recommenda-
tions given here may not be sufficient or appropriate for the
judgment of overall competence. Board specialty certification
is not a required part of these guidelines but rather is another
measure of expertise.
The ACC/AHA/ACP-ASIM Task Force on Clinical Com-
petence makes every effort to avoid any actual or potential
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Introduction
This statement is a revision and extension of the 1994
ACP/ACC/AHA document on clinical competence in inva-
sive cardiac electrophysiological studies (EPSs) (1) and the
1993 report on elective direct current cardioversion (DCCV)
(2). This statement is designed to assist in the assessment of
physicians’ competence on a procedure-specific basis. The
minimum education, training, experience, and cognitive and
technical skills necessary for the competent performance of
invasive cardiac EPSs, catheter ablation, and cardioversion
are specified. It is important to note that these are minimum
training and experience requirements for the assessment of
competence in these disciplines (or procedures) in the broad-
est sense. Whenever possible, the specifications are based on
published data that link these factors with competence or, in
the absence of such data, on the consensus of expert opinion.
The specifications are applicable to any practice setting and
can accommodate a number of ways in which physicians can
substantiate competence in the performance of specific pro-
cedures (3). Expertise in the performance of these procedures
in patients with infrequently encountered diagnoses or of less
commonly performed variations of standard procedures may
require additional experience or training. It is therefore
expected that even highly competent practitioners will occa-
sionally benefit from consultation with colleagues who have
even more highly specialized interests, experience, or skills.
In addition to members of ACC, AHA, and ACP-ASIM,
the Writing Committee was broadened to include a represen-
tative from the North American Society of Pacing and
Electrophysiology (NASPE). Representation by an outside
organization does not necessarily imply endorsement. In
addition to content peer reviewers, “official” reviewers were
provided by ACC, AHA, NASPE, and the American Board of
Internal Medicine (ABIM). This document was approved for
publication by the governing bodies of ACC and AHA. In
addition, NASPE’s governing board formally endorsed this
document.
Clinical Competence in Invasive EPS,
Catheter Ablation, and Cardioversion
Overview of the Procedure
Catheter techniques for the recording of the His bundle
potential in humans were first reported in 1969 by Scherlag et
al (4). Initially, data from EPSs were used to determine the
mechanisms of spontaneously occurring arrhythmias, includ-
ing atrioventricular (AV) conduction abnormalities, prema-
ture complexes, and a variety of tachycardias (5,6). Subse-
quently, techniques for programmed electrical stimulation
were developed, which permitted the reproducible initiation
of both supraventricular (6,7) and ventricular (8–10) arrhyth-
mias in the laboratory. Pacing protocols to characterize sinus
node function (11) and AV conduction (12) were also
introduced. Because sustained arrhythmias are often episodic
in nature or can terminate spontaneously or require interven-
tion before full clinical evaluation, invasive EPSs have
become a standard means of reproducing an arrhythmia in a
controlled laboratory setting.
In this report, the term “EPS” refers to a procedure that
involves the recording of intracardiac electrical signals and
programmed electrical stimulation. The EPS either may be
performed for diagnostic purposes only or may be part of a
combined diagnostic and therapeutic (eg, ablation) procedure.
Although a thorough description of EPSs is beyond the scope
of this document, the procedure is briefly outlined here.
An EPS requires the placement of electrode catheters for
pacing and recording in multiple cardiac chambers. The
designs of the catheters and the sites appropriate for their
placement are determined according to the nature of the
arrhythmia under investigation. Typically, each catheter will
have multiple electrode poles for both recording and local
stimulation. Many types of specially designed catheters have
been developed to facilitate recording and stimulation, and
new catheters are frequently introduced into clinical practice.
The intracardiac signals are acquired, amplified, filtered,
displayed, stored, and analyzed, either in real time or for
subsequent offline review. A potentially important part of an
EPS is the use of intracardiac recordings to determine
activation sequences during arrhythmias. This process is
usually called “mapping.” Analyses of the responses of an
arrhythmia to various pacing techniques are also components
of the mapping process.
EPSs provide clinically valuable diagnostic information. In
patients with bradyarrhythmias, EPSs are occasionally nec-
essary to clarify electrocardiographic phenomena or to ex-
plain symptoms that are possibly due to a transient, clinical
bradyarrhythmia. EPSs are useful to determine the mecha-
nisms and physiological characteristics and drug responses of
supraventricular tachycardias and to determine whether ar-
rhythmias are suitable for drug, device, or ablation therapy, as
described later in this document. In patients with ventricular
tachycardia, EPSs are useful to confirm the mechanism of the
arrhythmia, to assess the effects of pharmacological therapy,
and to select patients for nonpharmacological treatment.
Acute or follow-up testing for antiarrhythmic device efficacy
falls under the definition of “EPS.” These studies can often be
performed noninvasively through the device, but the place-
ment of temporary catheters may be necessary.
EPSs have also been used to assess the future risk of
serious antiarrhythmic events and to provide data on which
prophylactic therapy may be based (13). In patients with
undocumented symptoms that suggest an arrhythmia that was
not previously documented (eg, syncope or palpitations),
EPSs are frequently used to assess the patient’s predisposition
for spontaneously occurring arrhythmias (14).
Physicians involved in the performance of invasive EPSs
should be cognizant of the indications, contraindications, and
potential complications of the procedure in a given patient
(14,15). Absolute contraindications to EPSs are few but
include unstable ischemia, bacteremia or septicemia, acute
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decompensated congestive heart failure not caused by the
arrhythmia, major bleeding diathesis, and lower extremity
venous thrombosis, if femoral vein cannulization is desired.
The appropriate use of invasive EPSs therefore requires a
careful preprocedural assessment to ensure that the patient is
stable and able to tolerate the procedure.
In the vast majority of situations, an EPS is performed on
an elective basis. However, an EPS is justifiable in such
situations if an arrhythmia is the main or major cause of the
emergency, as occurs in patients with incessant ventricular or
supraventricular tachycardia. General indications for invasive
EPSs were recently described by the ACC/AHA Task Force
on Practice Guidelines, in conjunction with NASPE (16).
Justification for Recommendation
The recommendations for minimum education, training, ex-
perience, and skills necessary to perform EPSs are based on
a review of statements by ACP, ACC, and AHA (1,17); the
Canadian Cardiovascular Society (18); and the British Car-
diac Society and Royal College of Physicians (19); a report
from a Core Cardiology Training Symposium (COCATS)
(20); and policies of the Accreditation Council of Graduate
Medical Education (ACGME) (21) and ABIM (22) (Table 1).
The American groups (Table 1) recommend training after the
completion of 3 years of a general cardiology fellowship. The
British statement discusses specialized training in the last
year (year 6) of a cardiology fellowship. The Canadian
Cardiovascular Society describes 2 levels of specialized
training: level 2 may be achieved during 3 years of a general
cardiology fellowship program, whereas level 3 requires
additional years of training. In preparation of this document,
63 program directors were surveyed regarding training and
competency issues; 33 directors (52.4%) responded. Where
results pertaining to this document are available, they will be
indicated as CCEP Training Program Directors’ Survey
results.
The technical and cognitive skills required for CCEP are
listed in Tables 2 and 3. Expertise in invasive EPSs requires
the ability to safely and efficiently perform the catheterization
procedures for intracardiac recording and stimulation. The
operator must possess a thorough understanding of the basic
electrophysiological mechanisms and clinical manifestations
of arrhythmias, the applications and limitations of the avail-
able recording and stimulation technologies, the pharmaco-
logical effects of medications used during the studies, and the
risks, benefits, and applications of nonpharmacological ther-
apy. Because knowledge in all of these areas has increased,
the interpretation and application of data acquired in the
electrophysiological laboratory have become increasingly
complex. The accurate interpretation of data is critical for
optimal prescription of both pharmacological and nonphar-
macological therapies.
Minimum Training Necessary for Competence
There is general agreement that a minimum of 1 year of
specialized training in EPS is needed to acquire the cognitive
and technical skills required to become expert in CCEP. This
is in addition to time spent during general cardiology fellow-
ship training learning to diagnose and manage arrhythmias.
Training should take place in a laboratory that offers experi-
TABLE 1. Invasive EPS: Recommendation for Training to Achieve Competence
Source Training, y EPS, n
EPS in Patients With
Supraventricular
Tachycardia, n
Catheter
Ablation, n
Antiarrhythmic
Devices, n
ACP/ACC/AHA 1994* 1 100 NS NS NS
Canadian Cardiovascular
Society(18)
Level 2 1–2 100 NS NS NS
Level 3* 1–2 NS NS NS 20
British Cardiac Society(19)* 1 70 NS 50 NS
COCATS(20)* 1 100 50 50 50
ACGME(21)* 1 150 NS 75 25
ABIM(22)* 1 150 NS 75 25
Present document* 1 100 $50 50–75 NS
*Recommendations for last year of training.
NS indicates not specified. n indicates number performed or implanted.
TABLE 2. Some Technical Skills Needed to Perform EPS
Operational skills to perform right and left heart catheterization with
percutaneous techniques via femoral and other venous and arterial access
sites
Manual dexterity to safely place and manipulate electrode catheters in the
appropriate chambers for the arrhythmia under study
Ability to obtain appropriate recordings from various locations
Ability to safely perform programmed electrical stimulation
Ability to recognize and manage procedural complications (eg, vascular or
cardiac perforation)
Proficiency in the use of external defibrillation and intravenous cardiac
medications
Proficiency in the appropriate use of sedation during procedures, including
airway management
Proficiency in the testing, interrogation, and programming of implantable
antiarrhythmic devices, including pacemakers and defibrillators
Technical knowledge regarding the use of recording equipment, including
knowledge of electrical safety and pertinent radiation-related issues
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ence with a diverse patient population who manifest a broad
variety of arrhythmias. During the specialized training year, it
is recommended that each trainee be a primary operator and
analyze 100 to 150 initial diagnostic studies. At least 50 of
these procedures should involve patients with supraventricu-
lar arrhythmias. Because therapy with antiarrhythmic devices
forms a major part of current electrophysiology practice, the
trainee should also have been a primary operator during $25
electrophysiological evaluations of implantable antiarrhyth-
mic devices. The trainee’s experience should be documented
in writing and confirmed by the laboratory supervisor. For
each procedure during the training period, the following facts
should be documented: date, patient identification number,
patient age, indication, type of procedure, findings, and
complications. Respondents to the CCEP Training Program
Directors’ Survey uniformly indicated that 2 years were
required to achieve training in all aspects (diagnostic and
therapeutic) of CCEP.
Alternate Routes to Achieve Competence
In the absence of completion of the formal 1-year training
program, competence in CCEP is difficult to achieve. The
current requirement for residency education in CCEP as
stated by the ACGME is 1 year of training in an ACGME
electrophysiology program after the completion of an accred-
ited cardiovascular disease residency program (21). This
requirement must be met to sit for the ABIM subspecialty
examination in CCEP (22). For those who choose to gain
competency in the performance of EPSs but not within an
accredited US program, training should still be completed in
a structured environment. The operator should perform the
same number of the above-listed procedures as currently
recommended for US trainees. He or she should also partic-
ipate in courses designed to provide specific instruction in
CCEP. Prior competency statements have suggested a mini-
mum of 30 hours of continuing medical education (CME)
every 2 years; this recommendation is endorsed in the present
document. Any such training should be performed under the
supervision and mentorship of a recognized expert in the field
of cardiac electrophysiology who has achieved board certifi-
cation by the ABIM in CCEP or an equivalent degree of
training in countries outside the United States. The trainee
who completes this latter program in a training program that
is not approved by the ACGME will not be eligible to take the
ABIM examination.
Maintenance of Competence
As is true for many other procedures, a minimum number of
cases are necessary to ensure continued proficiency in quality
of care. The individual should participate in $100 diagnostic
EPSs per year to maintain skills and should attend $30 hours
of formal CME (level I category) every 2 years to remain
abreast of changes in knowledge and in technology.
Catheter Ablation
Overview of the Procedure
Catheter ablation has revolutionized the field of electrophys-
iology. The performance of catheter ablation was initially
accomplished through the delivery of high-energy, DC
shocks (23,24). These early procedures had limitations in
usefulness and safety because of barotrauma. They also
carried the potential for significant complications, such as
cardiac tamponade and the early or late occurrence of sudden
death (25,26). Technological advancements in the late 1980s
led to the ability to apply continuous-wave unmodulated
radiofrequency energy through catheters to heat myocardium
at the catheter–tissue interface, creating ablative lesions (27).
Although initial success rates were modest (27,28), further
development in technology resulted in a technique that has
replaced DC energy delivery (29,30). Radiofrequency abla-
tion has also quickly supplanted open-heart surgery for
several arrhythmias and is an acceptable alternative to long-
term drug treatment.
The lesions created by radiofrequency are well demarcated.
This characteristic, along with improved catheter technology,
allows very specific and focal energy delivery, which permits
the cure of many arrhythmias. Through targeting of the
specific site of origin of the arrhythmia, as with atrial
tachycardia, or through interruption of a critical pathway
needed for the maintenance of a reentrant arrhythmia, such as
an accessory pathway, many arrhythmias of various mecha-
nisms can be eliminated. Since its inception, catheter ablation
has grown tremendously in its application. The number of
reported ablation procedures performed annually in the
United States has increased from 450 in 1989 to ’15 000
annually (31). The success rates reported in the 1995 Schein-
man (31) survey of 157 laboratories in the United States
were 97% for AV node ablations, 90% for accessory path-
ways in all locations, 94% for AV node modifications in the
treatment of AV nodal reentry, 72% for the treatment of atrial
flutter, and 71% for the treatment of atrial tachycardia.
Complication rates derived from the Scheinman survey and
the 1993 Multicentre European Radiofrequency Survey
TABLE 3. Some Cognitive Skills Needed to Perform EPS
Knowledge of current indications for an EPS
Knowledge of contraindications for an EPS
Knowledge of potential complications and management of such
complications
Knowledge of normal and abnormal cardiac anatomy and electrophysiology
Knowledge of the anatomy and physiology of the normal AV conduction
system and accessory pathways
Understanding of the intracardiac electrocardiographic signals
Knowledge of various methods of programmed electrical stimulation
Ability to measure conduction intervals and refractory periods and
knowledge of their significance in normal and pathological states
Knowledge of the predictive value of electrophysiological testing in patients
with various arrhythmias and clinical syndromes
Ability to interpret data derived from electrophysiological testing
Knowledge of the indications for and complications of therapy with
antiarrhythmic devices
Knowledge of the pharmacology of antiarrhythmic drugs and of sympathetic
and parasympathetic agonists and antagonists
Knowledge of the indications for and complications of ablative therapy
Detailed knowledge of recent clinical trials that affect the selection of
patients for EPSs
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(MERFS) from 86 institutions (32) were reported in just
under 4% of AV node interruptions, 2.6% of accessory
pathway ablations, 1.7% of AV node modifications, and 1.6%
of flutter and atrial tachycardia ablations.
Although the incidence of complications is low, serious
complications can occur and include valvular disruption,
coronary occlusion, cerebrovascular accident, and death. In
US centers, procedural deaths occur in 0.2% of patients who
undergo AV node ablation and 0.1% of patients with acces-
sory pathways (31). The most common complication in AV
node modification has been the development of heart block
through the inadvertent ablation of both the fast and slow AV
nodal pathways. In the 1996 study from the MERFS (33),
4.7% of patients developed heart block during AV node
modification. Heart block was significantly higher in patients
in whom the fast pathway was targeted (5.3%) rather than the
slow pathway (2%). This is higher than the overall rate of
inadvertent heart block reported by Calkins et al (34) from the
Atakr Multicenter Ablation Investigators Group, in which the
incidence of inadvertent heart block in patients who under-
went AV node modification was 1.3%. Importantly, a slow
pathway ablation approach was used in this study. This study
also reported serious complications in 3% of patients and
minor complications in 8%.
Despite these complications, studies have clearly shown
that symptomatic patients are afforded important improve-
ments in the quality of life with catheter ablation (35–38).
The benefit gained through arrhythmia treatment with cathe-
ter ablation is superior to that achieved through medical
therapy. The cost of catheter ablation, although not trivial, is
less over time than the cost of alternatives such as medical
therapy or surgical interventions (35,39).
Catheter ablation provides a safe and highly effective
treatment for symptomatic patients with supraventricular
tachycardia. Ablation should not be reserved as a last resort
treatment but is appropriate to consider, in some cases, as
first-line therapy (eg, a symptomatic patient with Wolff-
Parkinson-White syndrome) (40–45). However, for patients
with rhythm disturbances that are likely to spontaneously
resolve (eg, atrial tachycardia) or unlikely to recur (eg, a first
episode of atrial flutter), ablation would not be appropriate
first-line therapy (46). Its role would be limited to patients in
whom medical therapy is intolerable or in whom there is
evidence for adverse consequences of the arrhythmia. The
complete list of indications is detailed in the ACC/AHA
guidelines for CCEP and catheter ablation procedures (16).
AV node reentry in a structurally normal heart typically is
a benign arrhythmia, and there is a reasonable chance that no
therapy is required (47). However, if patients have other
compounding heart disease, such as coronary artery disease,
or if the arrhythmia produces hemodynamic compromise or
intolerable side effects, ablation can be considered as first-
line treatment because of the high likelihood of recurrence or
of serious consequences to the arrhythmia (47).
The role of ablation in the treatment of atrial fibrillation
(AF) is still primarily restricted to AV node ablation and
pacemaker implantation when medical therapy is not success-
ful (37). Direct curative ablation of the AF may be feasible
for focal AF and shows some promising development but is
not yet ready to be considered a primary treatment for AF
(48).
Radiofrequency ablation has been applied in the treatment
of ventricular tachycardia in ischemic disease, bundle-branch
reentry, and idiopathic tachycardia (49–52). A decision to
perform an ablation in a patient with ventricular tachycardia
must take into account the risks and benefits of doing so as
well as subsequent risks of arrhythmia occurrence in abnor-
mal but unablated tissue.
Justification for Recommendations
The performance of catheter ablation requires skills detailed
previously as necessary for the performance of diagnostic
electrophysiological testing. The indications, contraindica-
tions, and complications for catheter ablation are largely
derived from the ACC/AHA guidelines for clinical intracar-
diac electrophysiological and catheter ablation procedures
(16). The performance of catheter ablation requires the ability
and dexterity to successfully manipulate catheters in all
locations of the heart to achieve adequate contact between the
catheter and the myocardium to create curative lesions. This
requires detailed knowledge of cardiac anatomy. Left-sided
arrhythmia substrates such as left atrial foci usually require
the ability to perform transseptal catheterization (53). In some
laboratories, this approach is routinely used for left-sided
accessory pathways as well. For these pathways, a knowledge
of transseptal and the retrograde aortic technique is needed
(53,54). A thorough knowledge of arrhythmia mechanisms
and the treatment of complex arrhythmias, including pharma-
cological effects, is a predicate to catheter ablation. The
ability to interpret complex mapping with multiple intracar-
diac electrograms is required.
Because the possibility of creating AV heart block through
the application of radiofrequency energy exists either as a
desired end point or as an inadvertent result of energy
application, physicians who perform ablations should be
capable of managing the bradyarrhythmia and AV heart
block.
Minimum Training Necessary for Competence
Program requirements for residency education in CCEP are
outlined by the ACGME and effective as of July 1999 (21).
Training in an accredited program is required for admission
to the ABIM examination for certification in CCEP. Pro-
grams accredited for training in CCEP must function as a part
of an accredited subspecialty fellowship in cardiovascular
disease. These programs should also meet the training in
specialized electrophysiology, cardiac pacing, and arrhythmia
management guidelines outlined by COCATS Task Force 6
(20).
The performance of catheter ablation procedures requires
skills that are developed over time. Several studies have
shown that success rates improve and fluoroscopy times
decrease with experience (55–58). Although there are many
determinants of arrhythmia recurrences, recurrence rates drop
with operator experience (59). Each of these studies involved
operators with extensive prior experience in electrophysiol-
ogy, and it would be expected that the number of procedures
required for a new trainee to gain expertise in ablation would
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be higher than that for an experienced electrophysiologist.
The risks of ablation similarly have been reported by expe-
rienced operators. The MERFS volunteer registry reported an
overall complication rate of 4.6% at high-volume centers
(.100 ablations/year) compared with 5.6% at low-volume
centers (,50 ablations/year) (32). Similar data were reported
in the 1994 NASPE survey, with a 1.5% complication rate at
high-volume centers (.50 cases/year) and a 3.2% rate at
low-volume centers (,20 ablations/year) (52).
It is strongly recommended that all physicians who per-
form ablations in the United States meet the minimum
ACGME training requirements for education in CCEP. Al-
though credentialing at most institutions does not require
board certification in CCEP, applicants should have met
board requirements. The current program requirements for
training in electrophysiology are for 12 months of specialty
training after the completion of training in cardiovascular
disease. This should provide adequate training for the perfor-
mance of routine electrophysiological procedures. Training in
electrophysiology and ablation techniques can occur simul-
taneously with incremental responsibility for the trainee
during the entire period. However, most training program
directors agree that to gain expertise in interventional elec-
trophysiology and catheter ablation, additional training is
required. Adequate training in all aspects of electrophysiol-
ogy, including ablation, is expected to take 1 to 2 years after
the completion of a 3-year training program in cardiovascular
disease (18,37,39,40,60,61).
It is anticipated that the more experienced the electrophysi-
ologist is, the quicker she or he will learn new techniques. As
such, it is difficult to set requirements for a number of
procedures to gain proficiency. The North American Society
of Pacing and Electrophysiology Ad Hoc Committee on
Catheter Ablation has recommended that a physician who
performs catheter ablation procedures should have been the
primary operator on $30 ablations (62); this should include
15 accessory pathway ablations. The Canadian Cardiovascu-
lar Society Committee (18) recommends a training experi-
ence that includes the performance of 50 transvenous catheter
ablations. The ACGME recommends a minimum of 75
catheter ablative procedures, including a mix of AV nodal
reentrant tachycardia, atrial flutter, AV junction ablation, and
ventricular tachycardia (21). For left-sided mapping proce-
dures, the COCATS guidelines (20) recommend 15 cases
with the retrograde aortic approach. For transseptal catheter-
ization experience, $10 procedures are recommended. The
COCATS guidelines also recommend participation in 50
catheter ablation procedures. It is the consensus of this task
force that for new trainees, the physician should be involved
in 75 ablation procedures. It is notable that for candidates
who take the first cardiac electrophysiology examination
given by the ABIM, the pass rates were significantly higher
for those who performed a greater number of ablations
compared with those who performed a lesser number of
procedures (63). The CCEP Training Program Directors’
Survey indicated that a minimum of 90 (mean; 100 median)
cases were required to acquire clinical competence in catheter
ablation.
Alternate Routes to Achieve Competence
At this time, it is anticipated that physicians who perform
ablations will have either received instruction during their
training or been among those who developed the technique.
In the rare instance of a board-eligible or -certified electro-
physiologist who desires to learn the techniques required for
ablation, mentoring by an electrophysiologist who is trained
in ablation should be pursued. Documentation of satisfactory
completion of such training should be kept in a log book. It is
anticipated that depending on the level of skill, a minimum of
75 procedures will be required. In addition, such an individ-
ual should participate in courses designed to provide specific
instruction in the cognitive and technical skills required for
catheter ablation as listed earlier.
Maintenance of Competence
The field of interventional electrophysiology is evolving
rapidly. Although it is anticipated that most physicians who
perform ablations will have received instructions during their
training, newer techniques will arise that require new skills or
adaptations of old skills. The maintenance of skills needed to
perform ablations successfully with acceptably low compli-
cation rates requires continued clinical activity. It is recom-
mended that physicians who perform ablations maintain a
volume of .20 to 50 ablations/year. The CCEP Training
Program Directors’ Survey respondents indicate that to main-
tain competency in catheter ablation, a mean of 38 (median
50) cases/year are required.
With the future development of new techniques, it is likely
that some form of retraining will be required. Every 2 years,
physicians who are involved in ablation therapy should attend
CME activities ($30 hours of category 1 credits) that pertain
to interventional electrophysiology. For novel treatments,
some form of monitoring should be considered. The CCEP
Training Program Directors’ Survey results indicated that to
maintain competency in the performance of diagnostic EPSs,
a mean of 49 (median 50) cases/year was required and that a
mean of 49 (median 50) could be in association with the
performance of ablation procedures.
Use of Emerging Technology and New
Techniques: Assessment of Clinical
Competence in Invasive Cardiac
Electrophysiological Procedures
During the past 10 years, the technology of cardiac electro-
physiology has evolved rapidly. The rather straightforward
electrophysiological procedures from the diagnostic era have
given way to the multicatheter techniques and accompanying
technologies that are necessary for interventional practice.
The 8- to 16-channel analog recording systems are being
replaced in routine procedures with 16- to 48-channel,
computer-based digital recording platforms. Furthermore, 48-
to 128-channel mapping capabilities are being developed and
increasingly applied in cardiac ablation procedures. These
systems not only simultaneously record and display activa-
tion from multiple regions of the heart but also format both
activation and voltage information in 3- and 4-dimensional
renderings.
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Electroanatomic magnetic mapping capabilities, for exam-
ple, are being applied to aid in the diagnosis and nonpharma-
cological treatment of arrhythmias (64,65). These systems
involve the interaction of a sensing unit in the catheter tip
positioned within a triangulating magnetic field to display
temporal activation in a 3-dimensional pseudoanatomic con-
text. Noncontact mapping probes are also being used to
record actual and virtual electrograms from the endocardial
surface of each heart chamber. With this technology, cardiac
activation can be displayed in terms of 3-dimensional iso-
chronal and full cardiac cycle isopotential maps (66,67).
Several other systems that use active signaling between
multiple exclusively intracardiac catheter electrodes or the
body surface and catheter electrodes are being developed to
provide a 3-dimensional framework for cardiac arrhythmias
(68,69). In each case, these new technologies increase the
amount and complexity of data generated during a mapping
procedure.
Two-dimensional fluoroscopic imaging is also being sup-
plemented with intracardiac echocardiography. This approach
has capabilities of visualizing cardiac structures, endocardial
surfaces, and the interaction between interventional catheters
and targeted structures that are superior to those available
with fluoroscopy (70–72). Although not yet established as
requisite or “core” equipment for the electrophysiology lab-
oratory, these and other emerging technologies have had, and
will continue to have, a major impact on the practice of
cardiac arrhythmia management. It is also anticipated that
additional new technologies will be developed at ever faster
rates in the future.
Competence in the Use of Emerging Technology
This evolution of new means of diagnosing and treating
arrhythmias is accompanied by an ever-increasing challenge
to the practicing electrophysiologist. Specifically, the use of
additional techniques and technologies will require the acqui-
sition of sufficient cognitive and technical expertise to ensure
safe and effective application. Although cardiac electrophys-
iology trainees may encounter these approaches and systems
during their fellowships, by default, the majority of clinical
electrophysiologists will first be exposed to, and begin using,
emerging techniques and technologies outside of their train-
ing experience. As such, the skills required to record, com-
pile, synthesize, integrate, render, interpret, and apply the
resulting data will be acquired through alternative educational
pathways.
Specific Training Requirements
The training required for proficiency in the application of
new technologies and techniques will depend on the technol-
ogy and procedures under consideration. When emerging
techniques and technology represent straightforward incre-
mental progress, their use may rely on already resident
cognitive and technical skills. For example, many new
intracardiac mapping technologies involve the same venous
and arterial access skills, arrhythmia induction protocols,
catheter positioning and mapping techniques, electrogram
pattern recognition, and arrhythmia mechanism deduction
previously acquired though years of training and clinical
practice. In these cases, training should be focused on the
appropriate operation of the system and interpretation and
application of data displays.
In other cases, however, application of the emerging
techniques and technology will undoubtedly represent a
major paradigm shift in interventional approaches, thus re-
quiring the accumulation of very different technical and
cognitive skills than those required to use the current proce-
dures or technology. In such cases, sufficient education and
experience are imperative for both understanding the general
operational principles behind that technology and ensuring
sufficient technical abilities for the safe and efficient appli-
cation of the technology. This exposure may come from
national and local CME seminars; emerging scientific infor-
mation from reputable, established scientific journals; local or
regional training sessions; or on-site teaching by certified
industry engineers. In any event, sufficient experience should
be acquired such that the actual application of the technology
and performance of the procedure are conducted safely under
the direction of the practicing physician, without relegation of
this responsibility to an industry representative. This obvi-
ously requires that a practitioner have a sufficient understand-
ing of appropriate indications, contraindications, and risks for
the application of that technology.
The duration of training or number of procedures required
to establish competence will be dependent on the new
techniques or technology used. This should be based on
definable measures of individual competence and should
include appropriate documentation of the specific cases
undertaken, arrhythmias under study, general techniques and
approaches used, and outcomes of the technology-related
procedures. It is fully anticipated that some new technologies
and techniques will lead to sufficiently specialized and
frequent applications so as to require subsequent, independent
competency guidelines. This has been the case in both
pacemaker and defibrillator implantation and in cardiac
ablation, as discussed in the preceding guidelines.
Finally, because of the additional complexity of interven-
tions enabled through emerging technology, cardiac electro-
physiology trainees may require additional time to acquire the
fundamental proficiency necessary for an interventional prac-
tice. In any event, it remains increasingly critical that the
practicing physician acquire and maintain an understanding
of relevant first principles of electrophysiology. Although it is
exciting, it should be kept in mind that the technology
facilitates the application of those fundamental principles of
electrophysiology only for the benefit of arrhythmia patients.
Clinical Competence in Elective DCCV
Overview of the Procedure
Since the introduction of DC transthoracic electrical shock
(73), its use has become fairly routine for the termination of
tachycardias. A variety of clinical scenarios are now encoun-
tered in which transthoracic and, more recently, intracardiac
DC electrical shock of variable energies is delivered
(24,26,51,74–76). In urgent settings such as hemodynamic
collapse associated with ventricular tachycardia or ventricular
fibrillation, high-energy shock (ie, $200 J) is used. However,
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lower energies are used for elective cardioversion in more
hemodynamically stable patients. Due to the potential risks
involved, it is imperative that physicians be familiar with
proper indications, precautions, techniques, and complica-
tions (77). Elective DCCV that requires sedation or general
anesthesia is the subject of this report. At the present time,
DCCV can be carried out externally with chest electrodes
(transthoracic) or endocardially with the use of electrode
catheters (or leads). The 2 procedures are discussed sepa-
rately where appropriate.
A. External Cardioversion
External cardioversion (2) is carried out in a fasting, postab-
sorptive state with the patient under sedation or general
anesthesia. A baseline 12-lead electrocardiogram is recorded,
and venous cannulation is secured. The rhythm is displayed
on the screen with a stable baseline. The electrodes (paddles)
are placed in the anteroposterior or base-apex location. For
atrial defibrillation, a more superoanterior left paddle position
is often more effective. A clearly visible artifact that indicates
the timing of the shock in relation to QRS is identified. DC
shock is synchronized to the peak of the QRS. Under no
circumstances should the shock be delivered on the T wave.
Although the selection of a specific R wave may not be
critical for high-energy depolarizing shock, it is desirable at
low energies. Recent data suggest that a perfectly synchro-
nized shock (to R wave) may still fall within the T wave of
the previous R wave after an R-R interval of ,300 ms (78).
Ideally, therefore, low-energy shocks should be synchronized
to an R wave preceded by a long R-R interval. This feature,
however, may not yet be available in commercially available
external cardioverters. Physicians in charge should be thor-
oughly familiar with the device that is used for elective
DCCV.
Once a satisfactory synchronization is obtained, sedation or
anesthesia is initiated, and a shock is delivered (79,80). The
initial shock energy may be as low as 50 J depending on the
type of arrhythmia. After shock delivery, the rhythm is noted,
and if conversion is unsuccessful, repeat DCCV is attempted
with higher energy. This can be repeated until the arrhythmia
terminates or a decision is made to abandon DCCV.
Before elective DCCV is performed, several precautions
are worth noting:
1. Anticoagulation (81–83). The most common arrhyth-
mia subjected to elective DCCV is AF. Individuals with
AF of .48 hours’ duration should receive warfarin
therapy for $3 weeks before and 4 weeks after the
procedure. An INR goal of 2.5 (range 2.0 to 3.0) is
recommended for most patients. For high-risk patients
such as those with mechanical heart valves, an INR goal
of 3 (range 2.5 to 3.5) is recommended. The routine use
of warfarin therapy in arrhythmias other than AF is still
controversial.
2. Although elective DCCV is effective in terminating a
variety of tachycardias, it has no role in the prevention
of subsequent episodes. In individuals with recurrent
episodes, it is desirable that some form of therapy be
planned for the prevention of the arrhythmia episodes.
For this purpose, class I and class III agents are usually
preferred and may be continued for a period of time
after DCCV (84). The concomitant use of AV nodal
blocking agents is frequent but may not be necessary
with the class III agents such as sotalol and amiodarone.
3. The use of transesophageal echocardiography has been
advocated to identify small atrial thrombi that are not
visible on transthoracic echocardiography. In patients in
whom earlier cardioversion is desired, anticoagulation
with heparin can be initiated and transesophageal echo-
cardiography can be performed. If no clots are seen,
cardioversion can be undertaken. Routine anticoagula-
tion must still be maintained after cardioversion (85).
4. Several untoward and potentially life-threatening events
may occur after DCCV shock: these include 1) the
induction of ventricular tachycardia/fibrillation, 2) asys-
tole, and 3) transient depression of myocardial function,
particularly with repeated shocks and higher energies.
Techniques to deal with these situations should be
readily available to prevent potential complications.
The use of an intravenous antiarrhythmic such as ibutilide
may result in the restoration of sinus rhythm, but if not, it may
facilitate DCCV in patients for whom conventional cardio-
version was unsuccessful (86,87).
B. Internal Cardioversion
In a significant number of patients for whom external DCCV
was unsuccessful, an internal shock with the use of electrode
catheters has been successful.(88,89) The primary indication
for internal DCCV is AF when external shock fails
(74,88,89). Evolution of this technology has facilitated the
TABLE 4. Cognitive Skills Necessary to Perform Internal DCCV
Physicians should have knowledge of the following:
Intracardiac EPS; principles as discussed in this report
Principles of intracavitary cardioversion with catheter technology, catheters,
chest electrodes, or whatever variant the operator plans to use
Indications and complications associated with transvenous catheterization
and with the intracavitary delivery of DC shock
The safe delivery of DC shock and the limit of energy that can be delivered
via electrode catheters
The use of conscious sedation or, when appropriate, anesthesia
The use of intravenous antiarrhythmic medications
Cognitive skills necessary for external DCCV (see Table 6)
TABLE 5. Technical Skills Necessary to Perform
Intracardiac DCCV
Competency in diagnostic cardiac EPS
Ability to place electrode catheters in appropriate locations for intracardiac
synchronization and DCCV
Familiarity with the catheter characteristics, synchronization, and DCCV
equipment
Ability to confirm the timing and energy of the shock for safe shock delivery
Adequate electrocardiographic and rhythm monitoring equipment
Ability to handle complications, including the use of temporary pacing and
defibrillation
Proficiency in the appropriate use of sedation during procedures, including
airway management
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development of stand-alone implantable atrial defibrillators
(76). An additional reason is to assess the feasibility of an
implantable atrial defibrillator (75).
Internal cardioversion is performed with the patient under
conscious sedation or general anesthesia (79,80). Specially
designed electrode catheters with large surface areas are
introduced percutaneously and placed in the right atrium and
coronary sinus. The large surface area is achieved with either
a coil or the connection of several electrodes to a common
terminal (75). A standard bipolar catheter is placed in the
right ventricle for precise timing of ventricular activation and
shock delivery. The 2 atrial catheters are used for DCCV (ie,
between the coronary sinus and right atrium).
Depending on the defibrillating device that is used, syn-
chronization to a particular R wave can be accomplished. Up
to 10 J of energy can be safely delivered with the right
atrium–coronary sinus vector, whereas 200 J has been safely
delivered via an intracardiac–thoracic patch combination. It is
important that the electrode catheters are kept away from the
region of the AV node–His bundle when internal DCCV is
performed. The postshock is analyzed, and the need for
further DCCV at a similar or higher energy is evaluated.
When symptomatic bradycardias are noted, they can be
treated with atrial or ventricular pacing, or both.
Because of the potential risk of bleeding, warfarin therapy is
usually withheld and resumed after the procedure. Temporary
anticoagulation before and after the procedure can be accom-
plished with heparin. Preprocedural and postprocedural antiar-
rhythmic therapy considerations are similar to those for external
DCCV. The possible risks of both right heart catheterization
with electrode catheters and the fact that the DC shock is
delivered within the myocardial structures add to specific com-
plications. The settings in which these procedures are carried out
must be equipped to handle all potential untoward sequelae.
Justification for Recommendation
The use of external as well as intracardiac DCCV is associ-
ated with a variety of serious risks to the patient. It is
therefore important that the physicians have the cognitive
skills and the technical know-how to safely conduct these
therapies. Tables 4 to 7 summarize the requirements that will
be considered essential to acquire.
The transthoracic procedure is widely used for the termination
of tachycardias in both chronic and emergent settings. There is a
broad-based pool of knowledge available regarding the clinical
settings in which DCCV is used, including indications, contra-
indications, complications, and technologies that are used. How-
ever, there is no formal mechanism to determine the expertise of
an individual who is qualified to perform DCCV. In previous
publications regarding external DCCV, ACP, ACC, and the
AHA Task Force collected data from accredited cardiology
training programs and made the recommendations.
For internal DCCV, a separate level of knowledge and skill
is required because of the invasive nature. Tables 4 and 5
outline the cognitive and technical skills needed to perform
effective and safe DCCV.
Minimum Training Necessary for Competence
For external DCCV, the minimum training should include
1) competence in the interpretation of 12-lead electrocardio-
grams and 2) cognitive knowledge and skills, outlined in
Tables 6 and 7. It is imperative that the technical skills
required to perform cardioversion are applied by those with
an overall understanding of the procedure. Improperly per-
formed DCCV can be both ineffective and harmful. Previous
task force recommendations of a minimum of 8 supervised
DCCVs seems appropriate as a minimum requirement. Al-
though typical training in cardiovascular disease during a
3-year period may provide such an experience, it should be
documented by the trainee and certified by appropriately
trained supervisors. If formal training in cardiovascular dis-
ease does not provide adequate exposure to a sufficient
number of DCCVs, competence in DCCV is not achieved.
Conversely, the competence in DCCV may be achievable
without formal training in cardiovascular disease.
For competency in internal DCCV, all of the above-
mentioned requirements for external DCCV must be met. It is
inconceivable that someone could meet the competency
criteria for internal DCCV without prior established mini-
mum training needed for external DCCV. In addition, how-
ever, the candidate must meet the minimum competency
requirement for the following:
1. Diagnostic invasive EPSs as mentioned elsewhere here.
2. Cognitive and manual skills to ensure the proper place-
ment of electrode catheters and additional chest elec-
trodes when necessary for internal DCCV.
TABLE 6. Cognitive Skills Necessary to Perform External DCCV
Physicians should have knowledge of the following:
Electrophysiological principles of DCCV
Indications for the procedure
Anticoagulation management
The proper use and administration of antiarrhythmic therapy
The use of sedation and the management of overdose
DCCV equipment, including the selection of appropriate energy and
synchronization
How to treat all possible complications, including the use of bradycardia
pacing, defibrillation, and advanced cardiovascular life support
Proper placement of external paddles
Appropriate monitor display and recognition of pre- and post-DCCV
arrhythmias
Baseline 12-lead electrocardiogram reading, recognition of acute changes,
drug toxicity, contraindication to DCCV
TABLE 7. Technical Skills Necessary to Perform
External DCCV
Proper preparation of the skin and electrode placement, including the
application of saline jelly
Achievement of artifact-free monitored strips and synchronization
signal/marker
Technically acceptable 12-lead electrocardiograms before and after DCCV
Temporary pacing and defibrillation capabilities
Ability to perform advanced cardiovascular life support, including proper
airway management
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3. Management of complications arising due to the proce-
dure. A minimum of 5 intracavitary DCCVs with use of
the right atrium–coronary sinus vector must be per-
formed under experienced (in intracardiac DCCV) in-
dividual supervision after the minimum criteria for
diagnostic EPSs are met. Demonstration of adequate
reading of didactic material and attendance of meetings
that address intracavitary DCCV with catheter technol-
ogy are also recommended. The supervisor must also
document in writing exactly what was accomplished
with the didactic exposure and during the procedures.
Privileges in diagnostic EPSs and even radiofrequency
ablation do not automatically qualify one to perform
intracardiac DCCV.
4. Periodic random examination of the outcomes may be
necessary to comply with standards of care, including
proper attention to record-keeping regarding indica-
tions, efficacy, and complications.
Maintenance of Competence
A minimum of 4 external DCCV procedures annually should
be necessary to maintain initial certification. It is also
important that a new body of knowledge be acquired as
additional reliable data become available. Varying and chang-
ing technology also necessitates that the operator be familiar
with the proper use of external DCCV equipment used in his
or her clinical settings.
The maintenance of competence in intracardiac DCCV
requires a minimum of 2 annual procedures. In addition,
necessary knowledge of upkeep and equipment changes must
be maintained. This, of course, is done with the understanding
that competency for diagnostic EPS is monitored concur-
rently. Individuals with experience in internal DCCV within
the institution should look at the issue from the quality
control perspective on a periodic basis. An outside consultant
may be necessary if institutional expertise is not available.
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